![](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/spacer.gif)
sorafenib tosylate![Patient Information Patient Information](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/btn-patient-info.gif) The tosylate salt of sorafenib, a synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/spacer.gif)
Synonyms: | ![](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/spacer.gif) | BAY 43-9006 BAY 43-9006 Tosylate Salt | | ![](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/spacer.gif) | US brand name: | ![](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/spacer.gif) | Nexavar | | ![](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/spacer.gif) | Abbreviation: | ![](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/spacer.gif) | SFN | | ![](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/spacer.gif) | Code name: | ![](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/spacer.gif) | BAY 54-9085 | | ![](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/spacer.gif) | Chemical structure names: | ![](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/spacer.gif) | - 2-pyridinecarboxamide, 4-[4-[[[[4-chloro-3- trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-
- 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate tosylate
| | ![](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090509173520im_/http://www.cancer.gov/images/spacer.gif) |